Cencora Inc. (ABG)
FSX
Closed
Oct 7, 2026
Day's Range
306.1552 wk Range
204.80Overview - ABG - Cencora Inc.
Key Statistics
Valuation
Enterprise Value
3.08T
P/E (Trailing)
‪16.82‬
PEG Ratio
‪0.05‬
Price / Sales (TTM)
‪8.03‬
Price / Book
‪6.60‬
EV / EBITDA
‪20.35‬
Profitability
Gross Margin
‪61.64%‬
Profit Margin
‪54.77%‬
Operating Margin
‪34.03%‬
Return on Assets
‪12.95%‬
Return on Equity
‪48.67%‬
Ownership
Shares Outstanding
12.22B
Float
10.87B
Held by Insiders
‪0.52%‬
Held by Institutions
‪62.12%‬
Price stats
Beta
‪1.22‬
50-Day Avg
‪297.25‬
200-Day Avg
‪289.94‬
Dividends
Payout Ratio
‪4.26%‬
Frequency
Quarterly
Market Cap - ABG - Cencora Inc.
Peers - ABG - Cencora Inc.
Peer Comparison
Compared with companies in Internet Content & Information listed on FSX.
Profile Summary - ABG - Cencora Inc.
About
Cencora Inc. is a global pharmaceutical solutions company focused on the sourcing, distribution, and commercialization of medicines and healthcare products. The company supports manufacturers, pharmacies, hospitals, health systems, and other care providers through wholesale distribution, specialty pharmacy services,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:

